Outcomes and relapse patterns following chemotherapy in advanced Hodgkin lymphoma in the positron emission tomography era

References

• CanellosGPAndersonJRPropertKJChemotherapy of advanced Hodgkin’s disease with MOPP, ABVD, or MOPP alternating with ABVDN Engl J Med199232721147814841383821
   PubMed Web of Science ®Google Scholar
• DugganDBPetroniGRJohnsonJLRandomized comparison of ABVD and MOPP/ABV hybrid for the treatment of advanced Hodgkin;s disease: report of an intergroup trialJ Clin Oncol200321460761412586796
   PubMed Web of Science ®Google Scholar
• FedericoMLuminariSIannittoEABVD compared with BEA-COPP compared with CEC for the initial treatment of patients with advanced Hodgkin’s lymphoma: results from the HD2000 Gruppo Ital-iano per lo Studio dei Linfomi TrialJ Clin Oncol200927580581119124807
   PubMed Web of Science ®Google Scholar
• GordonLIHongFFisherRIRandomized phase III trial of ABVD versus Stanford V with or without radiation therapy in locally extensive and advanced-stage Hodgkin lymphoma: an intergroup study coordinated by the Eastern Cooperative Oncology Group (E2496)J Clin Oncol201331668469123182987
   PubMed Web of Science ®Google Scholar
• HoskinPJLowryLHorwichARandomized comparison of the stanford V regimen and ABVD in the treatment of advanced Hodgkin’s Lymphoma: United Kingdom National Cancer Research Institute Lymphoma Group Study ISRCTN 64141244J Clin Oncol200927325390539619738111
   PubMed Web of Science ®Google Scholar
• JohnsonPWRadfordJACullenMHComparison of ABVD and alternating or hybrid multidrug regimens for the treatment of advanced Hodgkin’s lymphoma: results of the United Kingdom Lymphoma Group LY09 Trial (ISRCTN97144519)J Clin Oncol200523369208921816314615
   PubMed Web of Science ®Google Scholar
• SantoroABonadonnaGValagussaPLong-term results of combined chemotherapy-radiotherapy approach in Hodgkin’s disease: superiority of ABVD plus radiotherapy versus MOPP plus radiotherapyJ Clin Oncol19875127372433409
   PubMed Web of Science ®Google Scholar
• SkoetzNTrelleSRanceaMEffect of initial treatment strategy on survival of patients with advanced-stage Hodgkin’s lymphoma: a systematic review and network meta-analysisLancet Oncol2013141094395223948348
   PubMed Web of Science ®Google Scholar
• YahalomJRyuJStrausDJImpact of adjuvant radiation on the patterns and rate of relapse in advanced-stage Hodgkin’s disease treated with alternating chemotherapy combinationsJ Clin Oncol1991912219322011960560
   PubMed Web of Science ®Google Scholar
• YoungRCCanellosGPChabnerBAHubbardSMDeVitaVTJrPatterns of relapse in advanced Hodgkin’s disease treated with combination chemotherapyCancer1978422 Suppl10011007688174
   PubMed Web of Science ®Google Scholar
• BarringtonSFMikhaeelNGKostakogluLRole of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working GroupJ Clin Oncol201432273048305825113771
   PubMed Web of Science ®Google Scholar
• JohnsonPMcKenzieHHow I treat advanced classical Hodgkin lymphomaBlood2015125111717172325564404
   PubMed Web of Science ®Google Scholar
• MocciaAADonaldsonJChhanabhaiMInternational prognostic score in advanced-stage Hodgkin’s lymphoma: altered utility in the modern eraJ Clin Oncol201230273383338822869887
   PubMed Web of Science ®Google Scholar
• ChesonBDFisherRIBarringtonSFRecommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classificationJ Clin Oncol201432273059306825113753
   PubMed Web of Science ®Google Scholar
• LaskarSGuptaTVimalSConsolidation radiation after complete remission in Hodgkin’s disease following six cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine chemotherapy: is there a need?J Clin Oncol2004221626814657226
   PubMed Web of Science ®Google Scholar
• JohnsonPWSydesMRHancockBWCullenMRadfordJAStenningSPConsolidation radiotherapy in patients with advanced Hodgkin’s lymphoma: survival data from the UKLG LY09 random-ized controlled trial (ISRCTN97144519)J Clin Oncol201028203352335920498402
   PubMed Web of Science ®Google Scholar
• PhanJMazloomAAbboudMConsolidative radiation therapy for stage III Hodgkin lymphoma in patients who achieve complete response after ABVD chemotherapyAm J Clin Oncol201134549950521537149
   PubMed Web of Science ®Google Scholar
• AlemanBMRaemaekersJMTirelliUInvolved-field radiotherapy for advanced Hodgkin’s lymphomaN Engl J Med2003348242396240612802025
   PubMed Web of Science ®Google Scholar
• HasencleverDDiehlVA prognostic score for advanced Hodgkin’s disease. International prognostic factors project on advanced Hodgkin’s diseaseN Engl J Med199833921150615149819449
   PubMed Web of Science ®Google Scholar
• ChesonBDPfistnerBJuweidMEInternational Harmonization Project on LymphomaRevised response criteria for malignant lymphomaJ Clin Oncol200725557958617242396
   PubMed Web of Science ®Google Scholar
• AlemanBMRaemaekersJMTomisicREuropean Organization for Research and Treatment of Cancer (EORTC) Lymphoma GroupInvolved-field radiotherapy for patients in partial remission after chemotherapy for advanced Hodgkin’s lymphomaInt J Radiat Oncol20076711930
   PubMed Web of Science ®Google Scholar
• EngertAHaverkampHKobeCReduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin’s lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trialLancet201237998281791179922480758
   PubMed Web of Science ®Google Scholar
• Clinicaltrials.govFludeoxyglucose F 18-PET/CT Imaging in Assessing Response to Chemotherapy in Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Hodgkin Lymphoma Available from: https://clinicaltrials.gov/ct2/show/NCT00678327Accessed August 31, 2015
   Google Scholar
• Clinicaltrials.govS0816 Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III or Stage IV Hodgkin Lymphoma Available from: https://clinicaltrials.gov/ct2/show/NCT00822120Accessed August 31, 2015
   Google Scholar
• Clinicaltrials.govPositron Emission Tomography (PET)-Adapted Chemotherapy In Advanced Hodgkin Lymphoma (HL) (HD0607) Available from: https://clinicaltrials.gov/ct2/show/NCT00795613Accessed August 31, 2015
   Google Scholar
• Clinicaltrials.govHigh-dose Chemotherapy and Stem Cell Transplantation, in Patients PET-2 Positive, After 2 Courses of ABVD and Comparison of RT Versus no RT in PET-2 Negative Patients (HD0801) Available from: https://clinicaltrials.gov/ct2/show/NCT00784537Accessed August 31, 2015
   Google Scholar
• MeignanMGallaminiAHaiounCReport on the first International workshop on Interim-PET-Scan in LymphomaLeuk Lymphoma20095081257126019544140
   PubMed Web of Science ®Google Scholar